Evidence map›Paper›PMID 36994651›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Kinetic-Controlled Crystallization of α-FAPbI

Sooeun Shin, Seongrok Seo, Seonghwa Jeong, Anir S Sharbirin, Jeongyong Kim, Hyungju Ahn, Nam-Gyu Park, Hyunjung Shin

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Kinetic-Controlled Crystallization of α-FAPbIAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Sooeun ShinDepartment of Energy Science, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.
Seongrok SeoDepartment of Physics, University of Oxford, Clarendon Laboratory, Oxford, OX1 3PU, UK.
Seonghwa JeongDepartment of Energy Science, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.
Anir S SharbirinDepartment of Energy Science, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.
Jeongyong KimDepartment of Energy Science, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.
Hyungju AhnPohang Accelerator Laboratory, Pohang, Kyungbuk, 37673, Republic of Korea.
Nam-Gyu ParkSKKU Institute of Energy Science and Technology (SIEST), Sungkyunkwan University, Suwon, 440-746, Republic of Korea.ORCID https://orcid.org/0000-0003-2368-6300
Hyunjung ShinDepartment of Energy Science, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.ORCID https://orcid.org/0000-0003-1284-9098
Sungkyunkwan University · KRClarendon College · USPohang University of Science and Technology · KR

Funding

Korea Institute of Energy Technology Evaluation and Planning 20203040010320National Research Foundation of Korea NRF-2019R1A2C3009157National Research Foundation of Korea NRF-2021R1A3B1076723
6 · The paper itself

Abstract

Crystallization kinetic controls the crystallographic orientation, inducing anisotropic properties of the materials. As a result, preferential orientation with advanced optoelectronic properties can enhance the photovoltaic devices' performance. Although incorporation of additives is one of the most studied methods to stabilize the photoactive α-phase of formamidinium lead tri-iodide (α-FAPbI

Indexed as

crystallization kineticformamidinium lead triiodidemethylammonium chloride additiveperovskite solar cellphotovoltaic performancepreferred orientation

Identifiers

PMID36994651
PMCPMC10190499
OpenAlexW4361271590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.